High serum carotenoids are associated with lower risk for developing elevated serum alanine aminotransferase among Japanese subjects: The Mikkabi cohort study

British Journal of Nutrition

Volumn 115, Issue 8, 2016, Pages 1462-1469

  Sugiura, Minoru ^a   Nakamura, Mieko ^b   Ogawa, Kazunori ^a   Ikoma, Yoshinori ^a   Yano, Masamichi ^a  

^a NATIONAL INSTITUTE OF FRUIT TREE SCIENCE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alanine aminotransferase; Antioxidants; Carotenoids; Cohorts; Longitudinal cohort studies

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA CAROTENE; ASPARTATE AMINOTRANSFERASE; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN; ALPHA-CAROTENE; ANTIOXIDANT; RETINOL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FRUIT; HUMAN; HYPERTRANSAMINASEMIA; INCIDENCE; JAPANESE (PEOPLE); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; VEGETABLE; VITAMIN BLOOD LEVEL; BLOOD; ENZYMOLOGY; JAPAN; LIVER DISEASE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; RISK FACTOR;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIOXIDANTS; BETA CAROTENE; BETA-CRYPTOXANTHIN; CAROTENOIDS; COHORT STUDIES; FEMALE; HUMANS; JAPAN; LIVER DISEASES; LONGITUDINAL STUDIES; LYCOPENE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN A;

EID: 84959237800     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516000374     Document Type: Article

References (30)

1. Loguercio C, De Girolamo V, Federico A, et al. (2001) Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol Trace Elem Res 81, 245-254.
2. DeFronzo RA (2009) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links. The Claude Bernard Lecture 2009. Diabetologia 53, 1270-1287.
3. Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142, 711-725.
4. Gutteridge JM (1994) Biological origin of free radicals, and mechanisms of antioxidant protection. Chem Biol Interact 91, 133-140.
5. Rock CL, Jacob RA & Bowen PE (1996) Update on the biological characteristics of the antioxidant micronutrients: Vitamin C, Vitamin E, and the carotenoids. J Am Diet Assoc 96, 693-702.
6. Munoz SJ, Heubi JE, Balisteri WF, et al. (1989) Vitamin E deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, frequency and relationship to other lipid-soluble Vitamins. Hepatology 9, 525-531.
7. Rocchi E, Borghi A, Paolillo F, et al. (1991) Carotenoids and liposoluble Vitamins in liver cirrhosis. J Lab Clin Med 118, 176-185.
8. Leo MA, Kim CI & Lowe N (1992) Interaction of ethanol with -carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 15, 883-891.
9. Von Herbay A, De Groot H, Hegi U, et al. (1994) Low Vitamin E content in plasma of patients with alcoholic liver disease, haemochromatosis and Wilson's disease. J Hepatol 20, 41-46.
10. Rocchi E, Casalgrandi G, Ronzoni A, et al. (2001) Antioxidant liposoluble Vitamins and carotenoids in chronic hepatitis. Eur J Intern Med 12, 116-121.
11. Valtueña S, Pellegrini N, Franzini L, et al. (2008) Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr 87, 1290-1297.
12. Sanyal AJ, Chalasani N, Kowdley KV, et al. (2010) Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362, 1675-1685.
13. Arendt BM & Allard JP (2011) Effect of atorvastatin, Vitamin E and C on nonalcoholic fatty liver disease: is the combination required Am J Gastroenterol 106, 78-80.
14. Ruhl CE & Everhart JE (2003) Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology 124, 1821-1829.
15. Sugiura M, Nakamura M, Ikoma Y, et al. (2005) High serum carotenoids are inversely associated with serum gammaglutamyltransferase in alcohol drinkers within normal liver function. J Epidemiol 15, 180-186.
16. Sugiura M, Nakamura M, Ikoma Y, et al. (2006) Serum carotenoid concentrations are inversely associated with serum aminotransferases in hyperglycemic subjects. Diabetes Res Clin Pract 71, 82-91.
17. Sugiura M, Nakamura M, Ogawa K, et al. (2009) Synergistic interaction of cigarette smoking and alcohol drinking with serum carotenoid concentrations: findings from a middle-aged Japanese population. Br J Nutr 102, 1211-1219.
18. Japan Society of Ningen Dock (2015) http://www.ningendock. jp/public/method (accessed July 2015).
19. Pagano G, Pacini G, Musso G, et al. (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35, 367-372.
20. Dimitrov NV, Meyer C, Ullrey DE, et al. (1988) Bioavailability of beta-carotene in humans. Am J Clin Nutr 48, 298-304.
21. Rock CL & Swendseid ME (1992) Plasma beta-carotene response in humans after meals supplemented with dietary pectin. Am J Clin Nutr 55, 96-99.
22. Martucci RB, Ziulkoski AL, Fortuna VA, et al. (2004) Beta-carotene storage, conversion to retinoic acid, and induction of the lipocyte phenotype in hepatic stellate cells. J Cell Biochem 92, 414-423.
23. Sugiura M, Nakamura M, Ogawa K, et al. (2008) Associations of serum carotenoid concentrations with the metabolic syndrome: interaction with smoking. Br J Nutr 100, 1297-1306.
24. Sugiura M, Nakamura M, Ikoma Y, et al. (2006) The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol 16, 71-78.
25. Ni Y, Nagashimada M, Zhan L, et al. (2015) Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, -cryptoxanthin. Endocrinology 156, 987-999.
26. Goodner KL, Rouseff RL & Hofsommer HJ (2001) Orange, mandarin, and hybrid classification using multivariate statistics based on carotenoid profiles. J Agric Food Chem 49, 1146-1150.
27. Holden JM, Eldridge AL, Beecher GR, et al. (1999) Carotenoid content of U. S. foods: an update of the database. J Food Compost Anal 12, 169-196.
28. Sugiura M, Matsumoto H, Kato M, et al. (2004) Multiple linear regression analysis of the seasonal changes in the serum concentration of beta-cryptoxanthin. J Nutr Sci Vitaminol (Tokyo) 50, 196-202.
29. Montonen J, Knekt P, Järvinen R, et al. (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27, 362-366.
30. Rhee EJ & Plutzky J (2012) Retinoid metabolism and diabetes mellitus. Diabetes Metab J 36, 167-180.